DRUGS & SUPPLEMENTS
How old is patient?
Simvacor is a hypolipidemic agent from a group of statins, an inhibitor of HMG-CoA reductase. This medication is a prodrug because it has in its structure the closed lactone ring which is hydrolyzed after intake.
Lipid-lowering effect of statins is associated with lower levels of total cholesterol by LDL-C. Reducing cholesterol is dose-dependent and is not linear but exponential. Statins do not affect the activity of lipoprotein and hepatic lipase, have no significant effect on the synthesis and catabolism of free fatty acids, thats why their effect on TG levels again and indirectly through their main effects on reducing LDL-C.
According to the controlled studies of Simvacor increases HDL-C to 14%.
In addition to the hypolipidemic actions Simvacor has beneficial effects in endothelial dysfunction, on the vascular wall, the state of atheroma, improves blood rheology, have antioxidant, antiproliferative properties. There is evidence that Simvacor improves endothelial function within 30 days of therapy.
Simvacor therapy was accompanied by a decrease in the incidence of cardiovascular disorders, regardless of baseline LDL-C.
After oral administration Simvacor is well absorbed from the gastrointestinal tract (average 85%). Cmax is reached after 4 h. Taking Simvacor just before eating with low fat does not affect its the pharmacokinetic parameters.
During a "first pass" through the liver Simvacor biotransformed to form active beta-metabolites. The plasma protein binding is 95%.
The concentration of the active metabolite of Simvacor in human systemic circulation is less than 5%.
Excreted in unchanged form and as metabolites, mainly in the bile - 60-85%, 10-15% - in the form of inactive metabolites are excreted by the kidneys.
Primary hypercholesterolemia with the ineffectiveness of diets, combined hypercholesterolemia and hypertriglyceridemia.
The dosing regimen of Simvacor is individual. The initial dose is 5-20 mg. If necessary the dose is increased every 4 weeks. Simvacor is taken 1 time / day in the evening. The maximum dose is 40 mg / day.
For patients receiving immunosuppressive drugs, the recommended starting dose is 5 mg; the maximum dose is 5 mg / day.
In severe renal insufficiency, the initial dose is 5-10 mg / day.
Digestive system: constipation, diarrhea, loss of appetite, flatulence, nausea, abdominal pain, pancreatitis, increased ALT, AST, GGT, ALP.
CNS and peripheral nervous system: headache, dizziness, muscle cramps, paresthesia, peripheral neuropathy.
Cardiovascular system: possible transient hypotension.
Musculoskeletal system: myalgia, myopathy, rhabdomyolysis, increased CPK.
Allergic reactions: seldom - angioedema, lupus like syndrome, vasculitis, thrombocytopenia, eosinophilia, ESR increase, arthritis, rash, fever, shortness of breath.
Dermatological reactions: photosensitivity, skin rash, itching, redness of skin, alopecia.
An active pathological process in the liver, persistent elevation of transaminases, pregnancy, lactation, hypersensitivity to Simvacor.
Simvacor is contraindicated in pregnancy and lactation.
Category effects on the fetus by FDA - X.
With careful use Simvacor in patients with liver disease, with chronic alcoholism, with hypotension, reduced or increased tone of skeletal muscle of unknown etiology, epilepsy, severe renal insufficiency.
Before and during treatment it is necessary to monitor liver function.
Patients receiving anticoagulant coumarin derivatives, before and during treatment with Simvacor should monitor the prothrombin time.
Simvacor therapy should be discontinued if a significant increase in CK activity or suspected myopathy, the development of acute or severe illness when any risk factors predisposing to renal failure due to rhabdomyolysis.
It is not recommended to use Simvacor concurrently with immunosuppressants, fibrates, nicotinic acid, antifungal azole derivatives drugs.
Safety and efficacy of Simvacor in a pediatric practice are not established. It is not recommended to use this medication for children.
Simultaneous administration of Simvacor with:
Depending on the reaction of the Simvacor after taken, if you are feeling dizziness, drowsiness or any weakness as a reaction on your body, Then consider Simvacor not safe to drive or operate heavy machine after consumption. Meaning that, do not drive or operate heavy duty machines after taking the capsule if the capsule has a strange reaction on your body like dizziness, drowsiness. As prescribed by a pharmacist, it is dangerous to take alcohol while taking medicines as it exposed patients to drowsiness and health risk. Please take note of such effect most especially when taking Primosa capsule. It's advisable to consult your doctor on time for a proper recommendation and medical consultations.Is Simvacor addictive or habit forming?
Medicines are not designed with the mind of creating an addiction or abuse on the health of the users. Addictive Medicine is categorically called Controlled substances by the government. For instance, Schedule H or X in India and schedule II-V in the US are controlled substances.
Please consult the medicine instruction manual on how to use and ensure it is not a controlled substance.In conclusion, self medication is a killer to your health. Consult your doctor for a proper prescription, recommendation, and guidiance.
|It has side effects||1||100.0%|
There are no reviews yet. Be the first to write one!
The information was verified by Dr. Rachana Salvi, MD Pharmacology